Healthtech Startups

Iaso Automated Medical Systems is a medical device company developing machine learning-based technology to detect and manage Acute Respiratory Distress Syndrome (ARDS) in intensive care units. The company helps critical care teams make evidence-based decisions through early warning systems and clinical decision support for critically-ill patients.

1 investor

Ibabaza Media is an IT services and software development company serving businesses in East Africa and Sub-Saharan Africa. The company provides custom software development, mobile app development, website design, IT infrastructure support, social media marketing, and consulting services.

1 investor

IBI SA (Industrie Biomediche Insubri SA) researches, develops, and produces medical devices for tissue engineering and regenerative medicine, including bone substitutes, grafts, 3D matrixes, and 2D scaffolds.

1 investor

IbisVision provides a digital platform for eye care practices that includes online vision checks and remote patient monitoring to facilitate digital patient journeys. The platform enables eye care providers to attract, engage, and support patients across connected care pathways.

1 investor

Move AI is an AI-powered route optimization platform for non-emergency medical transportation (NEMT) providers, brokers, and managed care organizations. It automates trip planning, driver assignment, and real-time routing using Google Fleet Engine to reduce costs and improve operational efficiency.

1 investor

iCAD develops FDA-cleared, AI-based solutions for breast cancer detection, breast density assessment, and risk evaluation, used by radiologists in mammography workflows. Its offerings support 2D and 3D digital breast tomosynthesis screening to aid earlier cancer detection.

1 investor

Icon Bioscience develops biodegradable, sustained-release intraocular ophthalmic products using its proprietary Verisome drug delivery technology, targeting unmet needs in inflammation, glaucoma, and retinal disease treatment.

1 investor

Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.

1 investor

ICON plc is a global Contract Research Organization providing consulting and outsourced development services to pharmaceutical, biotechnology, medical device, and government organizations to accelerate drug and device development. The company supports clients across all phases of clinical development with integrated services spanning study design, patient recruitment, digital trial solutions, and commercialization.

1 investor

iContracts, part of Medispend, offers the Revenue Management Suite (RMS), an enterprise platform managing the contract-to-cash lifecycle for pharmaceutical manufacturers, covering chargebacks, rebates, government pricing, and Gross-to-Net forecasting. It also provides government compliance tools, analytics, and professional services for finance, compliance, and commercial teams in the life sciences industry.

1 investor

ICU Vision Care develops digital therapeutics for pediatric strabismus (crossed eyes), with plans to pursue FDA approval and eventual myopia management capabilities. The company operates vision care centers and provides customized vision examinations by specialized optometrists.

1 investor

Ideal Option operates office-based outpatient clinics providing medication-assisted treatment for opioid, alcohol, and other substance addictions across the United States. It serves patients seeking addiction recovery through a network of 80+ Joint Commission-accredited clinics and an in-house laboratory, accepting Medicaid, Medicare, and self-pay.

1 investor

Identifeye provides a fundus imaging platform combining a portable camera device and cloud-based portal software for retinal screening in point-of-care settings. The system serves healthcare providers and clinics conducting diabetic retinopathy and other retinal disease screenings.

1 investor

Idience is a biopharmaceutical company focused on developing and commercializing new medicines. Established in 2019 as a wholly owned subsidiary of Korean pharmaceutical group Ildong Holdings.

1 investor

IDmelon provides passwordless authentication using proximity badges and FIDO2 passkeys for healthcare organizations, enabling fast and secure access to clinical devices and applications without traditional passwords or complex MFA solutions.

1 investor

iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The implant uses a proprietary membrane with nanoporous material for controlled drug delivery as an alternative to daily eye drops.

1 investor

iECURE is a clinical-stage biotechnology company developing in vivo genome editing therapies that insert a functional copy of a gene into a patient's genome to treat rare, life-threatening genetic diseases in children. Its initial focus is on neurometabolic and urea cycle disorders, including ornithine transcarbamylase (OTC) deficiency.

1 investor

ieso develops AI-powered mental health support that integrates into existing healthcare platforms to treat anxiety and depression alongside chronic conditions. The platform targets healthcare providers, behavioral health platforms, and health plans seeking to improve care outcomes and reduce costs.

1 investor

A medical AI company that builds diagnosis and treatment reasoning systems, smart hospital and healthcare platforms, and AI health hardware such as hearing aids and blood pressure monitors. Its products serve hospitals, primary care providers, and patients, including AI diagnostic assistants, intelligent triage, chronic disease management, and an AI health assistant.

1 investor

IFM Therapeutics develops small-molecule drugs that target the innate immune system to treat inflammation-driven diseases and cancer. The company operates through independently financed R&D subsidiaries, each advancing programs aimed at key control nodes of innate immunity such as NLRP3 and cGAS/STING.

1 investor

iFocus Health provides a data-driven digital health platform that helps patients and caregivers make informed treatment decisions for ADHD, combining AI, bioinformatics, and clinical expertise to improve treatment outcomes.

1 investor

IFP Labs operates an integrated network of accredited analytical laboratories in Germany and the UK providing food safety testing, contaminant analysis, and regulatory compliance services. Services span chemical, physical, and microbiological testing for food, feed, water, environmental, and pharmaceutical samples, including nutritional profiling, allergen testing, and label compliance.

1 investor

IGNIA is a venture capital fund founded in 2007 that invests in early-stage startups solving problems in emerging markets, with a focus on Latin America market expansion. The fund serves as a bridge for regional startups pursuing international growth and for global startups entering Latin America.

1 investor

IGS develops imaging and visualization technology based on inverse scattering theory to enable observation of previously invisible structures and phenomena. The company applies this core technology to solve problems in medical imaging, energy, infrastructure, and security sectors.

1 investor